These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 26026120)

  • 1. Local therapy improvement of outcome in a patient with recurrent hepatocellular carcinoma after living donor liver transplantation: a case report.
    Shimokawa M; Itoh S; Ikegami T; Takeishi K; Harimoto N; Yamashita YI; Yoshizumi T; Kawanaka H; Shirabe K; Maehara Y
    Anticancer Res; 2015 Jun; 35(6):3525-9. PubMed ID: 26026120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living-donor liver transplantation for hepatocellular carcinoma.
    Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
    Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation.
    Morita K; Taketomi A; Soejima Y; Ikegami T; Fukuhara T; Iguchi T; Nagata S; Sugimachi K; Gion T; Shirabe K; Maehara Y
    Liver Transpl; 2009 Nov; 15(11):1412-6. PubMed ID: 19877253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive combined resection of hepatic inferior vena cava, with replacement by a ringed expanded polytetrafluoroethylene graft, in living-donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
    Matsuda H; Sadamori H; Shinoura S; Umeda Y; Yoshida R; Satoh D; Utsumi M; Onishi T; Yagi T
    J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):719-24. PubMed ID: 20425126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage living-donor liver transplantation for liver failure following definitive radiation therapy for recurrent hepatocellular carcinoma: a case report.
    Kitajima T; Fujimoto Y; Hatano E; Nishida H; Ogawa K; Mori A; Okajima H; Kaido T; Nakamura A; Nagamatsu H; Uemoto S
    Transplant Proc; 2015 Apr; 47(3):804-8. PubMed ID: 25891735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience of the transplant team is an important factor for posttransplant survival in patients with hepatocellular carcinoma undergoing living-donor liver transplantation.
    Majeed TA; Wai CT; Rajekar H; Lee KH; Wong SY; Leong SO; Singh R; Tay KH; Chen J; Tan KC
    Transplant Proc; 2008 Oct; 40(8):2507-9. PubMed ID: 18929781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW; Yi NJ; Suh KS
    Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of histological vascular invasion from preoperative evaluation in patients with hepatocellular carcinoma who underwent living donor liver transplantation.
    Sakai K; Okajima H; Koshino K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Ochiai T; Yoshimura N
    Transplant Proc; 2012 Mar; 44(2):409-11. PubMed ID: 22410029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
    Jiang L; Liao A; Wen T; Yan L; Li B; Yang J
    Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
    Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
    Hwang S; Lee SG; Joh JW; Suh KS; Kim DG
    Liver Transpl; 2005 Oct; 11(10):1265-72. PubMed ID: 16184545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting recurrence and survival after living donor liver transplantation for hepatocellular carcinoma.
    Abdel-Wahab M; Sultan AM; Fathy OM; Salah T; Elshobary MM; Elghawalby NA; Yassen AM; Elsarraf WM; Elsaadany MF; Zalatah K
    Hepatogastroenterology; 2013; 60(128):1847-53. PubMed ID: 24719918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
    Sandhu L; Sandroussi C; Guba M; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Levy G; Greig PD; Renner EL; Grant DR
    Liver Transpl; 2012 Mar; 18(3):315-22. PubMed ID: 22140013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Section 2. Small-for-size liver graft and hepatocellular carcinoma recurrence.
    Chan SC
    Transplantation; 2014 Apr; 97 Suppl 8():S7-S10. PubMed ID: 24849840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved results of a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation.
    Taketomi A; Fukuhara T; Morita K; Kayashima H; Ninomiya M; Yamashita Y; Ikegami T; Uchiyama H; Yoshizumi T; Soejima Y; Shirabe K; Maehara Y
    Ann Surg Oncol; 2010 Sep; 17(9):2283-9. PubMed ID: 20204531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma.
    Hwang S; Lee SG; Moon DB; Ahn CS; Kim KH; Lee YJ; Ha TY; Song GW
    Liver Transpl; 2007 May; 13(5):741-6. PubMed ID: 17457860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.
    Lee SD; Kim SH; Kim YK; Kim C; Kim SK; Han SS; Park SJ
    Transpl Int; 2013 Jan; 26(1):50-60. PubMed ID: 23106431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.